✦ LIBER ✦

A review of the proteasome inhibitor bortezomib in multiple myeloma

✍ Scribed by Richardson, Paul G

Book ID: 118029169
Publisher: Informa plc
Year: 2004
Tongue: English
Weight: 192 KB
Volume: 5
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656566.5.6.1321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteasome inhibitor bortezomib for the

Proteasome inhibitor bortezomib for the treatment of multiple myeloma

✍ Cavo, M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 217 KB

Bortezomib in the Treatment of Multiple

Bortezomib in the Treatment of Multiple Myeloma Volume 1106 || Second-Generation Proteasome Inhibitors

✍ Ghobrial, Irene M.; Richardson, Paul G.; Anderson, Kenneth C. 📂 Article 📅 2010 🏛 Springer Basel 🌐 German ⚖ 526 KB

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin

Proteasome inhibitors in the treatment o

Proteasome inhibitors in the treatment of multiple myeloma

✍ Shah, J J; Orlowski, R Z 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 605 KB

Pleomorphic presentation of cutaneous le

Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma

✍ Ka Lung Wu; Freerk Heule; King Lam; Pieter Sonneveld 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Proteasome inhibitor for treatment of mu

Proteasome inhibitor for treatment of multiple myeloma

✍ Khabir Ahmad 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 61 KB

A novel orally active proteasome inhibit

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

✍ Dharminder Chauhan; Laurence Catley; Guilan Li; Klaus Podar; Teru Hideshima; Mug 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 873 KB